P3 Diagnostics, LLC (“P3”) serves to foster the business development of technology created under the direction of Benjamin Larimer, PhD, and The Larimer Lab. Current Projects In March 2020, Dr. Larimer sought to utilize his knowledge of peptides to develop a method of antibody detection for COVID-19 in the human body. In July 2020, a provisional patent was issued. There are many participants in this testing environment, but our technology is different. This is because rather than using widely available anti
Chris is a Co-Founder of P3 Diagnostics LLC and serves on its Board of Managers as CEO. Chris has served in numerous financial and operating positions within portfolio companies of private equity sponsors.
Ben is a Co-Founder of P3 Diagnostics LLC and serves on its Board of Managers as Chief Science Officer.